Philips Respironics Clinical Trials
Sponsors / Philips Respironics
ClinicalTrials.gov lists 49 trials for which Philips Respironics is named as lead sponsor. Of these, 1 are recruiting, 0 are active without new recruitment, and 37 have completed. The registry records 7 terminated or withdrawn trials for Philips Respironics. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Planned participant enrollment across these trials sums to 5,439. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
49
Total Trials
1
Recruiting
0
Other Active
37
Completed
7
Terminated / Withdrawn
5,439
Total Enrollment
Termination reasons: Recruitment57% · Other29% · Funding14%
Recent Terminations
- NCT03851510 Stopped Nov 2023Chronic Obstructive Pulmonary Disease"Study discontinued due to shifted business priorities."
- Bronchiolitis"Difficulties with patient inclusion"
- Breathing-Related Sleep Disorder"Difficulty recruiting patient population."
- Heart Failure"lack of funding"
- Chronic Obstructive Pulmonary Disease"Study had a high screen fail rate, enrollment was open over a year, only 3 completed."
- NCT01964339 Stopped May 2014Obesity Hypoventilation Syndrome"This study was stopped due to low recruitment."
- Sleep Disordered Breathing"Sub par recruitment performance"
Active Trials (0 total)
- NCT03621566